Cepheid (NASDAQ:CPHD) delivered a profit and beat Wall Street’s expectations, AND beat the revenue expectation. The revenue beat is a positive sign to shareholders seeking high growth out of the company. Shares are up 0.02%.
Cepheid Earnings Cheat Sheet
Results: Adjusted Earnings Per Share decreased 0% to $0.02 in the quarter versus EPS of $0.02 in the year-earlier quarter.
Revenue: Rose 18.49% to $96 million from the year-earlier quarter.
Actual vs. Wall St. Expectations: Cepheid reported adjusted EPS income of $0.02 per share. By that measure, the company beat the mean analyst estimate of $-0.04. It beat the average revenue estimate of $92.57 million.
Quoting Management: Chairman and Chief Executive John L. Bishop on Thursday said, “With backorders of Xpert test cartridges now behind us, and with new leadership and a new organizational structure in manufacturing operations, we are investing aggressively and driving across-the-board improvements to ensure that Cepheid is well prepared to effectively manage the growing demand for our rapidly expanding Xpert test menu.”
Key Stats (on next page)…